The possible impact of pre-transfusion laboratory interference

Authors

  • Luís Moura Unidade Local de Saúde Viseu Dão-Lafões, Viseu, Portugal https://orcid.org/0000-0003-1319-4337
  • Liliana Fonseca Unidade Local de Saúde Viseu Dão-Lafões, Viseu, Portugal http://orcid.org/0000-0001-7294-8077
  • Emanuel Rodrigues Unidade Local de Saúde Viseu Dão-Lafões, Viseu, Portugal
  • Rui Lobo Unidade Local de Saúde Viseu Dão-Lafões, Viseu, Portugal
  • Arnaldo Brito Unidade Local de Saúde Viseu Dão-Lafões, Viseu, Portugal
  • Mariana Costa Unidade Local de Saúde Viseu Dão-Lafões, Viseu, Portugal

DOI:

https://doi.org/10.29352/mill0216e.36799

Keywords:

laboratory interference; therapeutic plasmapheresis; crossmatch; transfusion

Abstract

Introduction: Pre-transfusion tests allow the detection of clinically significant antibodies and the prior compatibility of units to be transfused.

Objective: To describe a clinical case treated with plasmapheresis and immunosuppression.

Methods: Descriptive study of a clinical case of a 55-year-old man, hospitalized for rapidly progressive renal failure, treated with plasmapheresis and immunosuppression to reduce/remove the pathological immune component responsible for interfering with pre-transfusion tests. Daily monitoring of the clinical situation was carried out using laboratory tests of specific blood parameters.

Results: The decrease in antibody titters, due to the action of the immunosuppressants used in association with the TPE sessions, in addition to the clear clinical impact on the recovery of renal function, also made it possible to remove this interference and select the blood units more safely.

Conclusion: It is essential to develop methods that identify and remove pathological substances that could interfere with the compatibility of units to be transfused and, therefore, with transfusion safety.

Downloads

Download data is not yet available.

References

Walsh, M., Collister, D., Zeng, L., Merkel, P. A., Pusey, C. D., Guyatt, G., Peh, C. A., Szpirt, W., Ito-Hara, T., & Jayne, D. R. W. (2022). The effects of plasma exchange in patients with ANCA-associated vasculitis: An updated systematic review and meta-analysis. BMJ, 376, e064604. https://doi.org/10.1136/bmj-2021-064604

Fortuny, L., & Thibodeaux, S. (2022). Recognition and resolution of common drug interference in routine blood bank testing. ASCP Case Reports. https://abrir.link/avpsY

Connelly-Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., Witt, V., Zantek, N. D., & Dunbar, N. M. (2023). Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue. Journal of Clinical Apheresis, 38(2), 77–278. https://doi.org/10.1002/jca.22043

Harmening, D. (2019). Modern Blood Banking & Transfusion Practices, 7thedition. F.A. Davis.

Downloads

Published

2024-12-17

How to Cite

Moura, L., Fonseca, L., Rodrigues, E., Lobo, R., Brito, A., & Costa, M. (2024). The possible impact of pre-transfusion laboratory interference. Millenium - Journal of Education, Technologies, and Health, (16e), e36799. https://doi.org/10.29352/mill0216e.36799

Issue

Section

Life and Healthcare Sciences